Area of Interest
|
|
Movement disorders - Parkinson's disease and Huntington's disease
|
|
|
Age-related neurological disorders - Gait and Balance
|
|
|
Neurodegenerative disease - Alzheimer disease and other Dementias
|
|
|
Autonomic disorders
|
|
Education
|
|
1996: Program for Chiefs of Clinical Services, Harvard School of Public Health, Boston, MA
|
|
1978-1980: Teacher-Investigator Development Award, National Institute of Neurological and Communicative Disorders and Stroke (NINCDS), Cornell University Medical Center
|
|
1977-1978: Jordan Research Fellowship, National Paraplegia Foundation, Cornell University Medical Center
|
|
1976-1980: Neurobiology Research Fellowship, Laboratory of Developmental Neurobiology, Cornell University Medical College, New York, NY
|
|
1976-1978: National Research Service Award, National Institute of Neurological and Communicative Disorders and Stroke, Cornell University Medical Center
|
|
|
1975-1976: Alfred P. Sloan Foundation Fellowship, Laboratory of Developmental Neurology, Cornell University Medical College
|
|
|
1973-1976: Neurology Resident, New York Hospital, Cornell University Medical College, New York, New York
|
|
1970-1973: Medical Officer (Internist), Lieutenant Commander, United States Navy
|
|
|
1968-1970: Medical Intern and Resident, Strong Memorial Hospital, University of Rochester School of Medicine and Dentistry, Rochester, New York
|
|
|
1968: M.D. Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina
|
|
|
1964: B.S., Springfield College, Springfield, Massachusetts
|
|
Appointments
|
|
1999-2001: Board of Trustees, University Medical Education Association, Inc., UVM College of Medicine
|
|
1995-present: Physician Leader, Neurology Health Care Service, Fletcher Allen Health Care, Burlington, VT
|
|
|
1994-1996: Board of Trustees, University Medical Education Association, Inc., UVM College of Medicine
|
|
|
1993-present: Professor and Chair, Department of Neurology, University of Vermont, College Medicine, Burlington, Vermont
|
|
|
1993-present: Dean's Advisory Committee, University of Vermont College of Medicine
|
|
|
1993-1994: President, University Associates of Neurology, Burlington, Vermont
|
|
|
1989-1993: Professor of Neurology, Neurobiology and Anatomy, and Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York
|
|
|
1987-1989: Associate Professor of Neurology, Neurobiology and Anatomy and Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York
|
|
|
1985-1987: Associate Professor of Neurology, Medicine and Brain Research, University of Rochester School of Medicine and Dentistry, Rochester, New York
|
|
|
1980-1993: Director, Neurology Unit, Monroe Community Hospital and Director, Neurogerontology Unit, Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York
|
|
1980-1985: Assistant Professor Neurology, Medicine and Brain Research, University of Rochester School of Medicine and Dentistry
|
|
|
1976-1980: Assistant Professor of Neurology, Department of Neurology, Cornell University Medical College, New York, New York
|
|
Board Certification
|
1979: American Board of Neurology and Psychiatry
|
|
Licensure
|
|
1993-present: Medical Licensure, State of Vermont
|
|
|
1976-present: Medical Licensure, State of New York
|
|
Professional Activities
|
|
2003-2006: ASENT Program Committee Chair
|
|
|
2002-present: Board of Directors, Progressive Supranuclear Palsy Society
|
|
|
2001-2002: Board Review Examiner, American Board of Psychiatry and Neurology, Part II Exam, Philadelphia and New York.
|
|
|
2000-present: Movement Disorder Society
|
|
|
1999-present: American Society for Experimental Neurotherapeutics
|
|
|
1999-present: Medical Director, American Parkinson's Disease Association, Information and Referral Center, University of Vermont/Fletcher Allen Health Care
|
|
|
1998: Consultant, Alzheimer’s Association; Ronald and Nancy Reagan Research Institute: The Care of People with Alzheimer’s Disease in the Next Millennium. Feb. 22 – Feb. 25.
|
|
|
1997: Member, Americian Federation for Aging Research, National Scientific Advisory Council
|
|
|
1995: Chair, NIA, Ad Hoc Study Center to review Alzheimer Disease Center, Washington, DC
|
|
|
1995-2000: Vermont State Commission on Alzheimer's Disease and Related Disorders
|
|
|
1994-present: Assistant Health Officer, Town of Underhill, Underhill, VT.
|
|
|
1994: Consultant Reviewer for Veterans Health Services and Research Admin. Proposal
|
|
|
1994: Chair, NIA, Ad Hoc Study Center to review Alzheimer Disease Center, Bethesda, MD
|
|
|
1994: Chair, NIA Review Panel for Older Americans Independence Centers (Pepper Centers)
|
|
|
1993-present: Northern New England Neurological Society (NH/VT/ME)
|
|
|
1993-present: Vermont State Medical Society (Chittenden County)
|
|
|
1993: Chair, NIA Ad Hoc Study Center to review Pepper Center Proposals
|
|
|
1987-present: American Neurological Association
|
|
|
1987-present: American Academy of Neurology, Fellow
|
|
|
1987-1993: Alzheimer’s Disease and Related Disorders Association, Inc., Rochester, N.Y., Board of Directors, Medical Advisor
|
|
1978-1980: Teacher-Investigator Development Award, National Institute of Neurological and Communicative Disorders and Stroke (NINCDS), Cornell University Medical Center
|
|
|
1975-present: Society for Neuroscience
|
|
|
1973-present: American Academy of Neurology
|
|
Awards and Honors
|
|
1996-2006: Best Doctors of America
|
|
|
1996-1997: Who’s Who
|
|
|
1964-1968: Hartford County Memorial Scholarship, Hartford County Medical Society, Hartford, CT
|
|
|
1964-1968: Charles Alva Stickland Scholarship, Bowman Gray School of Medicine
|
|
|
Magna Cum Laude Graduate, Wake Forest University, School of Medicine
|
|
|
Alpha Omega Alpha Honor Society, Springfield College
|
|
Research
|
2002-2007: 1 U10 NS44501-01 Hamill (PI) NINDS—NET-PD Neuroprotective Experimental Neurotherapeuticis in Parkinson’s Disease-Clinical Centers. UVM/FAHC is one of 52 sites that are conducting interventional trials designed to test agents that might slow or retard the progress of PD. The UVM site is a consortium among UVM, Dartmouth Hitchcock and Maine Medical Center.
Project I: A multi-center, double blind, futility study of Minocycline and Creatine in subjects with early untreated Parkinson's disease.
Project II: NIH Trial- A multi-center, double-blind, pilot study of CoQ10 and GPI 1485 in subjects with early untreated Parkinson's disease.
Subproject: DNA Repository for Patients with Parkinson’s Disease
|
|
|
2001-2011: P20 RR16435 Parsons (PI) NIH/NCRR Center for Excellence in Neuroscience (Centers of Biomedical Research Excellence-COBRE). The aims of this award are 1) to support the research development of a core group of five junior neuroscience faculty, 2) to establish a mentoring program to support junior neuroscience faculty, 3) to establish an imaging/physiology core, 4) to establish a cellular/molecular core, 5) to establish a University-wide Neuroscience Seminar Series and Annual Neuroscience Retreat, 6) to establish a mechanism of communication between basic scientists and clinicians that facilitates development of translational research and 7) to establish a University-wide mechanism for Neuroscience Graduate Education.
|
|
|
1999-present: Renewed annually “Parkinson’s Disease-Information and Referral Center Development” American Parkinson’s Disease Association Hamill (PI), Infrastructure for clinical care and education, including education regarding research opportunities. The goal of this project is to develop an information and referral center for patients with Parkinson’s disease.
|
|
Publications
|
|
The NINDS NET-PD Investigators: A Randomized Clinical Trial of Coenzyme Q10 and GPI-1485 in Early Parkinson’s Disease. (In Preparation)
|
|
|
The NINDS NET-PD Investigators: A randomized, double-bind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology 2006;66:664-671
|
|
|
B.C. Tilldy, Y.Y. Palesch, K. Kieburtz, B. Ravina, PO. Huang, J.J. Elm, K. Shannon, G. F. Wooten, C.M. Tanner, G.C.. Goetz and on behalf of the NET-PD Investigators Neurology 2006; 66:628-633
|
|
Klünemann HH, Sklarjevski V, Hamill RW. Accidental treatment of glioblastoma multiforme with intravenous tPA. Journal of Stroke & Cerebrovascular Diseases 2003;12:47-48 ISSN 1052-3057
|
|
|
Lew SM, Khoshyomn S, Hamill RW, Tranmer TI: Cavernous malformation of the facial colliculus. Neurology 58:79-84, 2002
|
|
Andersen JK, Mo TQ, Hom DG, Lee EY, Harnish P, Hamill RW, McNeil TH: Effect of Buthionine sulfoxamine, a synthesis inhibitor of the antioxidant glutathione on the murine nigro-striatal neurons. J Neurochem 67:2164-2171, 1996.
|
|
|
Rubio A, Steinberg K, Figlewicz DA, MacDonald ME, Greenamyre T, Hamill R, Shoulson I, Powers JM. Coexistence of Huntington disease and familial amyotrophic lateral sclerosis: case-presentation. Acta Neuropathologica 92:421-427, 1996.
|
|
Maguire-Zeiss KA, Shimoda LMN, Hamill RW: Calbindin D28k mRNA levels in olivopontocerebellar atrophy. Molecular Brain Research 30:362-366, 1995.
|
|
Hamill RW, Pilgrim DM: Advances in Alzheimer's Disease. Contemporary Internal Medicine 7(7)46-58, 1995.
|
|
Hamill RW, Pilgrim DM. Current Diagnostic Guidelines for Alzheimer's Disease. Contemporary Internal Medicine 7(5)45-54, 1995.
|
|
Maguire-Zeiss KA, Li ZW, Shimoda LMN, Hamill RW. Calbindin D28k mRnA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer Disease subjects. Molecular Brain Research 30:362-366, 1995.
|
|
|
Wetzel DM, Bohn MC, Kazee AM, Hamill RW. Glucocorticoid receptor mRNA in Alzheimer's diseased hippocampus. Brain Research, 679: 72-81, 1995.
|
|
Hamill RW, Pilgrim DM. Current Diagnostic Guidelines for Alzheimer's Disease. Contemporary Internal Medicine 7(5) 45-5, 1995.
|
|
|
Wetzel DM, Bohn MC, Hamill RW. Postmortem stability of mRNA for glucocorticoid and mineralcorticoid receptor in rodent brain. Brain Res 649:117-121, 1994.
|
|
|
Hamill RW, Markesbery WR, McDaniel KD, Coleman PD. Characterization of Brain Samples in Studies of Aging, Alzheimer's and Other Neurodegenerative Diseases. Neurobiol Aging 14:539-545, 1993.
|
|
|
Benesch CG, McDaniel KD, Cox C, Hamill RW: Alzheimer's Disease: Glasgow Coma Scale and the Neurologic Examination. Archives of Neurology 50:1309-1315, 1993.
|
|
